Showing 1421-1430 of 3189 results for "".
Encouraging Conversation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/Two studies validate the 40-GEP test for identifying patients most likely to benefit from adjuvant radiation therapyRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-19/23381/Taking the Pulse of Device-based Aesthetics Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/taking-the-pulse-of-device-based-aesthetics-procedures/22956/With new developments in store, the evolution of devices for aesthetic procedures is creating new possibilities.Case Report: Henoch-Schönlein Purpura in an Adult; Resident Salary Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-henoch-schnlein-purpura-in-an-adult-resident-salary-report/20909/A Practical Approach: Field Treatment of AKs with PDT
https://practicaldermatology.com/issues/supplements/a-practical-approach-field-treatment-of-aks-with-pdt/20431/Why it's essential to treat visible and invisible actinic keratosis lesions and how PDT fits into the treatment armamentarium.Conversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with HiDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Conversations in Acne, Part 2
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-2/19871/From isotretinoin to antibiotics—including next generation tetracyclines—the experts talk about key considerations for optimal outcomes, including the impact of diet. They also discuss management of trunk acne and strategies to reduce the risk for bacterial resistance. Host Neal Bhatia, MD leads theQuarantine Quorum: Circling the Wagons
https://practicaldermatology.com/topics/practice-management/quarantine-quorum-circling-the-wagons/18180/With Quarantine Quorum, host Neal Bahtia, MD provides a diary of life during the COVID-19 pandemic, talking to members of the dermatology community as they adapt to ongoing changes in their personal and private lives. In this edition, Hilary Baldwin, MD; Adam J. Friedman, MD; Mark Kaufmann, MD; andThe Gender Gap in Dermatology: Where Are We Now?
https://practicaldermatology.com/topics/general-topics/the-gender-gap-in-dermatology-where-are-we-now/20820/Despite advances, women are still not equally represented in academic dermatology or dermatology leadership.